GDNF and Parkinson disease: Intranasal delivery of SLNs encapsulating neurotrophic factors such as GDNF has demonstrated enhanced behavioral recovery, reduced oxidative stress, and protection of dopaminergic neurons in models of PD in preclinical studies [184,185].